I am a
Home I AM A Search Login

Papers of the Week

2021 May 21

Neurol Sci

Impact of COVID-19 on chronic migraine treated with erenumab: a case report.


Grassini A, Marcinnò A, Roveta F, Gallo E, Cermelli A, Boschi S, Rubino E, Rainero I
Neurol Sci. 2021 May 21.
PMID: 34021438.


Headache is a frequent symptom of the novel coronavirus 19 disease (COVID-19). To date, there are limited information on how COVID-19 affects migraine and its treatment.